ALOX15B activation in ulcerative colitis.
Fuente:
Zenodo
Saved in:
| Main Author: | Mamoor, Shahan |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2025
|
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
SLX1B is active during transformation and controls relapse and resistance in human cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Adirf activation in chronic disease.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Ribosomal activation in TNBC resistance in vitro.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
PAXX is activated in aging blood cells.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Chemokine activation during cellular senescence.
by: Mamoor, Shahan
Published: (2024)
by: Mamoor, Shahan
Published: (2024)
Importin 8 is activated in childhood brain cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Leukotriene activation in the blood of humans with high CRP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Alox5 activation in the blood of humans with high CRP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Gasdermin activation during lineage specification in the human embryo.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
TSC22D4 gene activation in Crohn's Disease.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
NLRP11 detects activation of CIDE cell death effectors.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Arid5b is activated early in human embryonic development.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: CAPN15.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Ep300 activation defines a common epigenetic route in chronic disease.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
Fam234b is selectively activated during the first cell division of the human embryo.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Phosphatase targeting in Luminal B breast cancer: PGP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Phosphatase targeting in Luminal B breast cancer: PNKP.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Kinase targeting in Luminal B breast cancer: DTYMK.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Kinase targeting in Luminal B breast cancer: CDK5.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Deletion of repeat B and C of Xist results in induction of SATB1.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Immunoglobulin-based therapeutic targeting for treatment of metastasis to the skeletal system: ABHD17B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: BCL11B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: PPP1R12B.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
by: Mamoor, Shahan
Published: (2026)
by: Mamoor, Shahan
Published: (2026)
NLRP7 engagement in transformation and etiology of chronic disease.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Telomerase control of Xist through Trf2.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Similar Items
-
SLX1B is active during transformation and controls relapse and resistance in human cancer.
by: Mamoor, Shahan
Published: (2025) -
Adirf activation in chronic disease.
by: Mamoor, Shahan
Published: (2025) -
Ribosomal activation in TNBC resistance in vitro.
by: Mamoor, Shahan
Published: (2025) -
PAXX is activated in aging blood cells.
by: Mamoor, Shahan
Published: (2025) -
Chemokine activation during cellular senescence.
by: Mamoor, Shahan
Published: (2024)